| Value | ₹200.0 Cr |
|---|
NSE filing, NSE: OMPOWER. Summary written from the filing by ALFA Finder's alert engine.
Om Power Transmission Ltd: key numbers
- Share price
- ₹130.16
- Market cap
- ₹445.7 Cr
- Revenue (annual)
- ₹449.2 Cr
- Net profit (annual)
- ₹40.02 Cr
- P/E (TTM)
- 9.0×Sector 21.3×
- Promoter holding
- 69.05%+0.00% QoQ
- FII holding
- 3.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Om Power Transmission Ltd
All →Om Power Transmission Management Change
Om Power Transmission's CFO Chetan Modi resigned, effective after business hours on 2 November 2026. He also ceases as the Regulation 30(5) authorised person for materiality disclosures.
Om Power Transmission Earnings Call Transcript: Key Takeaways
Q2 revenue rose 56.4% to ₹128.29 Cr, but the 15.25% EBITDA margin was project-mix driven. Management guides a normalised 12–13%. H1 operating cash flow was −₹38.2 Cr.
- Call
- Guides 50% growth
Om Power Transmission Investor Presentation: Key Takeaways
Q2FY27 revenue ₹12,829L (+56% YoY), EBITDA ₹1,956L (15.2% margin), PAT ₹1,385L (+117%). H1FY27 revenue ₹24,993L (+46%). Strategy: move up value chain to 765kV/HVDC, expand pan-India.
Om Power Transmission Q2 FY27 Results: Net Profit ₹13.8 Cr, Up 115.6% YoY
Om Power Transmission Ltd reported revenue from operations of ₹128.3 Cr (+56.5% YoY) and net profit of ₹13.8 Cr (+115.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹13.8 Cr · +115.6% YoY
Om Power Transmission Board Meeting Date
Om Power Transmission Ltd scheduled its Board to meet October 31, 2026 to approve Q1/H1 FY27 results. Trading window stays closed until 48 hours post-declaration.
Om Power Transmission Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulation 31(1)(b).
Other credit rating announcements
All →Sahajanand Medical Technologies Credit Rating
CRISIL has upgraded Sahajanand Medical Technologies' long-term bank facility rating to CRISIL A-/Stable from BBB+/Stable. The upgrade reflects improved business risk, growing scale, and sustained profitability across its global stent manufacturing operations.
- Value
- ₹300.0 Cr
Consolidated Construction Consortium Credit Rating
Consolidated Construction Consortium Ltd has withdrawn its credit rating facility provided by ICRA Limited. The company continues to maintain its rating facility with Infomerics Valuation and Rating Ltd.
I G Petrochemicals Credit Rating
India Ratings & Research affirmed and assigned IND AA-/Stable/IND A1+ to IG Petrochemicals' bank loan facilities. The rating signals sustained credit strength for the company's debt instruments.
Bank of Maharashtra Credit Rating
CRISIL reaffirmed its Crisil A1+ rating on Bank of Maharashtra's Certificate of Deposits. No new money is involved, only a rating action on existing securities.
DEE Development Engineers Credit Rating
DEE Development Engineers' bank facilities were upgraded by CARE Ratings to CARE A; Stable and CARE A2+/A1. Long-term facilities were reduced to Rs.169.19 crore, while combined and short-term limits were enhanced.
Subros Credit Rating
ICRA assigned or reaffirmed Subros's bank facility ratings, with total rated facilities rising from Rs.305 Crore to Rs.370 Crore. The long-term term loan rating is [ICRA]AA (Stable), raised to Rs.140 Crore from Rs.40 Crore.